Virios Therapeutics, Inc. (VIRI)
NASDAQ: VIRI · IEX Real-Time Price · USD
0.234
+0.012 (5.41%)
At close: Jul 2, 2024, 4:00 PM
0.237
+0.003 (1.28%)
After-hours: Jul 2, 2024, 7:56 PM EDT
Virios Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Virios Therapeutics stock has a target of 1.00, which predicts an increase of 327.35% from the current stock price of 0.23.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for VIRI is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $1 | Strong Buy | Initiates | $1 | +327.35% | Jun 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 20, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 15, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.28
from -0.28
EPS Next Year
-0.19
from -0.28
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 19.7M | 38.7M |
| Avg | n/a | n/a | n/a | 19.1M | 37.6M |
| Low | n/a | n/a | n/a | 18.4M | 36.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 102.7% |
| Avg | - | - | - | - | 96.9% |
| Low | - | - | - | - | 89.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.28 | -0.17 | -0.16 |
| Avg | -0.28 | -0.19 | -0.26 |
| Low | -0.26 | -0.21 | -0.34 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.